Navigation Links
ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2010 Financial Results

IRVINE, Calif., Oct. 15 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced it will release third quarter 2010 financial results after market close on November 2, 2010. In conjunction, the Company will host a conference call at 4:30 p.m. Eastern Time focusing on its commercial progress and pipeline updates, conducting a question and answer session after each set of formal comments.  Date: Tuesday, November 2, 2010Time: 4:30 p.m. Eastern TimeConference call access:Internet: www.istavision.comDomestic dial-in: 866-202-1971International dial-in: 617-213-8842Passcode: 22888741To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 97091207. This conference call also will be webcast live and archived on ISTA's website until December 31, 2010.

About ISTA Pharmaceuticals

ISTA Pharmaceuticals, Inc. is the fourth largest and fastest growing branded prescription eye care business in the United States, with an expanding focus on allergy therapeutics. ISTA currently markets four products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis. The Company's development pipeline contains additional candidates in various stages of development to treat dry eye, ocular inflammation and pain and nasal allergies. Headquartered in Irvine, California, the Company generated 2009 revenues of $111 million. For additional information about ISTA Pharmaceuticals, please visit the corporate website at

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Isis Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Syndax Pharmaceuticals Announces Issuance of UK Patent for Entinostat
3. Anadys Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
4. Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of AcetadoteĀ® in Australia
5. Prolong Pharmaceuticals Secures $30 Million in Funding
6. Amylin Pharmaceuticals to Webcast Third Quarter Results
7. Lexicon Pharmaceuticals to Present at BioCentury Newsmakers in the Biotech Industry Conference Oct. 22nd
8. Titan Pharmaceuticals Announces Journal of the American Medical Association Publication of Phase 3 Probuphineā„¢ Data
9. Cempra Pharmaceuticals Names Richard Kent, M.D., to Its Board of Directors
10. Reportlinker Adds Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies Adoption of New Sales Models and Technologies
11. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
(Date:6/23/2016)...  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas ...
(Date:6/23/2016)... June 23, 2016 The vast majority of ... dialysis facility.  Treatments are usually 3 times a week, ... visit, including travel time, equipment preparation and wait time. ... especially grueling for patients who are elderly and frail.  ... nursing and rehabilitation centers for some duration of time. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):